Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-13

Clinical Trial Update: Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether dexmedetomidine improves quality of recovery in patients with non-functioning pituitary adenoma undergoing endoscopic transs…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Non-functioning Pituitary Adenoma | Phase 2 | Status: UNKNOWN